Wu, Mh., Yuan, B., Liu, Qf. et al. Study of Qingre Liyan Decoction (清热利咽汤) in treating and preventing acute radioactive oral mucositis., Chin. J. Integr. Med. 13, 280–284 (2007). https://doi.org/10.1007/s11655-007-0280-9
Wu Min-hui, Yuan Bin, Liu Qiu-fang, et al. Study of Qingre Liyan Decoction (清热利咽汤) in treating and preventing acute radioactive oral mucositis. [J]. Chinese Journal of Integrative Medicine 13(4):280-284(2007)
Wu, Mh., Yuan, B., Liu, Qf. et al. Study of Qingre Liyan Decoction (清热利咽汤) in treating and preventing acute radioactive oral mucositis., Chin. J. Integr. Med. 13, 280–284 (2007). https://doi.org/10.1007/s11655-007-0280-9DOI:
Wu Min-hui, Yuan Bin, Liu Qiu-fang, et al. Study of Qingre Liyan Decoction (清热利咽汤) in treating and preventing acute radioactive oral mucositis. [J]. Chinese Journal of Integrative Medicine 13(4):280-284(2007) DOI: 10.1007/s11655-007-0280-9.
Study of Qingre Liyan Decoction (清热利咽汤) in treating and preventing acute radioactive oral mucositis
摘要
To study the effect of Qingre Liyan Decoction (清热利咽汤
QRLYD) in the prevention and treatment of acute radiative oral mucositis (AROM)
and to explore the mechanism of QRLYD by detecting epidermal growth factor (EGF) and T lymphocytes (CD3
CD4
and CD8). Sixty patients conforming with the standard were randomly assigned to two groups
30 patients in each group. Patients in the trial group were treated with QRLYD
and those in the control group were treated with Dobell’s solution
both groups receiving conventional radiation treatment. The treatment course for both groups was 6 weeks on average. Blood routine test
CD3
CD4
and CD8 in the peripheral blood and EGF in the saliva were detected one day before and on the 14th and 28th day of radio-therapy. Patients in the trial group were in good condition with normal spirits and intake of food and drinks. The incidence of AROM is lower and the effect in preventing AROM is higher in the trial group than those in the control group (P<0.05). The EGF in saliva
and CD4 and CD8 in the blood of patients in the trial group were higher than those in the control group (P<0.05). QRLYD can cure and prevent AROM. The mechanism may be related with its effects in enhancing body immunity and promoting salivary EGF.
Abstract
To study the effect of Qingre Liyan Decoction (清热利咽汤
QRLYD) in the prevention and treatment of acute radiative oral mucositis (AROM)
and to explore the mechanism of QRLYD by detecting epidermal growth factor (EGF) and T lymphocytes (CD3
CD4
and CD8). Sixty patients conforming with the standard were randomly assigned to two groups
30 patients in each group. Patients in the trial group were treated with QRLYD
and those in the control group were treated with Dobell’s solution
both groups receiving conventional radiation treatment. The treatment course for both groups was 6 weeks on average. Blood routine test
CD3
CD4
and CD8 in the peripheral blood and EGF in the saliva were detected one day before and on the 14th and 28th day of radio-therapy. Patients in the trial group were in good condition with normal spirits and intake of food and drinks. The incidence of AROM is lower and the effect in preventing AROM is higher in the trial group than those in the control group (P<0.05). The EGF in saliva
and CD4 and CD8 in the blood of patients in the trial group were higher than those in the control group (P<0.05). QRLYD can cure and prevent AROM. The mechanism may be related with its effects in enhancing body immunity and promoting salivary EGF.
Gu XZ, Yin WB, Liu TF, et al. eds. Radiation therapy of tumor. 2nd ed. Beijing: Beijing Medical University and Peking Union Medical College Press, 1994:356.
Shen WJ, Wang LH, eds. Therapeutic radiation injury. 1st ed. Beijing: China Medico-Pharmaceutical Sciences and Technology Publishing House, 2002:116–121.
Huang GX, Zhang P, Qiu HJ, et al. Chinese medicinal prevention and treatment of acute radiation oropharyngitis in patients with nasopharyngeal carcinoma. J Sun Yat-sen Univ (Med Sci) (Chin) 2003;24(1):54.
Yu JM, Xu ZF, eds. General clinical lesson of oncology. 1st ed. Jinan: Shandong Sciences and Technology Publishing House, 2004:300–329.
Beetz A, Messer G, Oppel T, et al. Induction of interleukin 6 by ionizing radiation in a human epithelial cell line: control by corticosteroids. Int J Radiat Biol 1997;72:33–43.
Asa B, Henrik L, Carl S, et al. Potent corenterold cream (mometason furoate) significantly reduces acute Nacliating dermatitis: results from a double-blind randomized study. Radiat Oncol 2001;59:257–265.
Wong ZG. Current state and expectation on research of skin radiation injury. Chin J Radiat J Med Prod (Chin) 1996;16: (4)218–219.
Halperin EC. Gaspar L, George S, et al. A double-blind randomized prospective trial to evaluate topical vitamin C solutind for the prevention of radiation dermatitis. Int J Radiat Oncol Biol Phys 1993;26:413–416.
Li SY, Gao L, Yin WB, et al. Effect of Gene time on acute radiation mucositis and dermatitis. Chin J Radiat Oncol (Chin) 2002;11(1):30–33.
Zhao T, Wei HB, Li X, et al. Observation on preventing and controlling mouth mucositis of 41 cases with therapy of nourishing yin to produce body fluid after radiotherapy of nasopharyngeal cancer. Beijing Univ Tradit Chin Med (Clinical Medicine) (Chin) 2003;10(3):16–17.